Collegium Pharmaceutical Inc (NASDAQ:COLL)
| 21.78 Delayed Data As of Jun 09 |  -0.16 / -0.73%Today’s Change | 15.10 Today|||52-Week Range 30.22 | -6.12% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 1.7M | 28.5M | 280.4M | |
| Cost of Goods Sold | 0.00 | 213.0K | 2.0M | 54.8M | ||
| Depreciation And Amortization | 171.0K | 655.0K | 594.0K | 110.9M | ||
| Operating Expenses | Gross Income | -171.0K | 843.0K | 25.9M | 114.7M | |
| General Expenses | 26.7M | 94.9M | 99.5M | 135.4M | ||
| Research And Development | 8.0M | 14.9M | 8.6M | 8.7M | ||
| Total Operating Expenses | 26.9M | 95.8M | 102.1M | 301.1M | ||
| Non-Operating Expenses | Operating Income | -26.9M | -94.1M | -73.6M | -20.7M | |
| Extraordinary Credit | 91.0K | 0.00 | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | 0.00 | -1.8M | 0.00 | ||
| Interest Expense On Debt | 439.0K | 94.0K | 0.00 | 20.1M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -27.3M | -94.2M | -74.9M | -39.1M | |
| Preferred Dividend | -24.6M | 0.00 | 0.00 | 0.00 | ||
| Extraordinary Items | 31.8M | 0.00 | 0.00 | 0.00 | ||
| Net Income | -27.3M | -94.2M | -74.9M | -39.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 13.5M | 24.3M | 30.3M | 33.0M | |
| Shares To Calculate EPS Diluted | 13.5M | 24.3M | 30.3M | 33.0M | ||
| Earnings Per Share | EPS | -$1.48 | -$3.88 | -$2.47 | -$1.19 | |
| EPS Diluted | -$3.83 | -$3.88 | -$2.47 | -$1.19 | ||
